Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Healthcare system still suing patients after being sold

A healthcare system in Tennessee is still suing patients for uncollected debt even after it’s been sold and some of its facilities were repurposed by the buyer. 

healthcare value value-based care money dollar

Only 5.6% of hospitals comply with price transparency rule

The vast majority of hospitals are not following through on a recent requirement to publish their list prices online, according to a recent study from PatientRightsAdvocate.com.

 

Thumbnail

CMS may charge hospitals for not posting prices online

The Centers for Medicare and Medicaid Services has proposed charging hospitals that fail to post their list prices online as required. 

 

Thumbnail

Johnson & Johnson settles opioid case with New York for $230M

Johnson & Johnson will pay New York State $230 million in a settlement over a lawsuit against the drug manufacturer for its role in the opioid epidemic. 

 

LGBTQ care lesbian gay rainbow

Biden administration reverses Trump-era healthcare discrimination rule

The Department of Health and Human Services has overturned a Trump-era rule that would have allowed healthcare providers to discriminate against patients based on sexual orientation or gender identity. 

 

Biden administration waives protections for COVID-19 vaccines

The Biden administration has backed the waiving of intellectual property protections for COVID-19 vaccines, supporting a proposal from the World Trade Organization to improve worldwide vaccinations against the deadly virus.

 

Thumbnail

Biden administration promotes new Obamacare subsidies in $50M campaign

The American Rescue Plan, the $1.9 trillion Covid-19 relief law that provided stimulus checks to most Americans, included several healthcare changes that will reduce costs for many Americans. The Biden administration is now preparing to spend $50 million in advertising to promote those healthcare changes,

FTC files suit to stop Illumina’s $7.1B takeover of life sciences firm

The Federal Trade Commission is suing Illumina, a gene sequencing firm, in an effort to stop its proposed $7.1 billion acquisition of life sciences firm Grail. 

 

Displaying 689 - 696 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup